Ovarian Cancer Panel - Disclosures
|
Panel Member
|
Ronald Alvarez MD, MBA |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Deborah Armstrong MD |
|
Grant/Research Support
|
| AstraZeneca Pharmaceuticals LP | Eisai Inc. |
|
Date Completed
|
07/03/2024 |
|
Panel Member
|
Floor Backes MD |
|
Grant/Research Support
|
| AstraZeneca Pharmaceuticals LP | GSK | Merck & Co., Inc. | Natera | Tempus |
|
Date Completed
|
02/11/2025 |
|
Panel Member
|
Lisa Barroilhet MD, MSc |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kian Behbakht MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Andrew Berchuck MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Marian Birkeland PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicole Blankenhorn |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Lee-may Chen MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Joshua Cohen MD, FACOG, FACS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Marie DeRosa RN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Eric Eisenhauer MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
David Gershenson MD |
|
Equity Interest/Stock Options
|
| Bristol Myers Squibb | Johnson & Johnson | Procter and Gamble |
|
Royalty Income
|
| Elsevier | UpToDate |
|
Date Completed
|
05/13/2025 |
|
Panel Member
|
Heidi Gray MD |
|
Royalty Income
|
| UpToDate |
|
Date Completed
|
01/06/2025 |
|
Panel Member
|
Kristina Gregory MSN, RN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Rachel Grisham MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ardeshir Hakam MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Brianna Herron PharmD, BCOP, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Hesler |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Angela Jain MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Gottfried Konecny MD |
|
Product/Speakers Bureau
|
| AstraZeneca Pharmaceuticals LP | ImmunoGen, Inc. | Merck & Co., Inc. |
|
Date Completed
|
08/09/2024 |
|
Panel Member
|
Emily Kovach BS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Charles Leath III MD, MSPH |
|
Grant/Research Support
|
| AbbVie, Inc. | Agenus | AstraZeneca Pharmaceuticals LP | Corcept Therapeutics | GSK | ImmunoGen, Inc. | Imunon | Merck & Co., Inc. |
|
Date Completed
|
07/03/2024 |
|
Panel Member
|
Gary Leiserowitz MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Babak Litkouhi MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Joyce Liu MD, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Lainie Martin MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Daniela Matei MD |
|
Grant/Research Support
|
| National Cancer Institute | Pinot bio |
|
Date Completed
|
01/27/2025 |
|
Panel Member
|
Michael McHale MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
David Miller MD, FACOG, FACS |
|
Grant/Research Support
|
| Acrivon | ADVENCHEN LABORATORIES LLC | Agenus | ASCENDIS PHARMA ONCOLOGY DIVISION A/S | Eisai Inc. | Incyte Corporation | Karyopharm Therapeutics | Merck & Co., Inc. | VERASTEM, INC | ZENTALIS PHARMACEUTICALS, INC. |
|
Date Completed
|
03/02/2025 |
|
Panel Member
|
John Moroney MD |
|
Royalty Income
|
| Wolters Kluwer |
|
Date Completed
|
07/30/2024 |
|
Panel Member
|
Aaron Oliver PharmD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Svitlana Ostanina PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sanja Percac-Lima MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Swathi Ramakrishnan PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Elena Ratner MD, MBA |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sharon Robertson MD, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kerry Rodabaugh MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
John Schorge MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Bettyanne Sunderland BSN, OCN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Premal Thaker MD |
|
Equity Interest/Stock Options
|
| Imunon |
|
Grant/Research Support
|
| GSK | Merck & Co., Inc. | SeaGen | Verastem |
|
Date Completed
|
07/31/2024 |
|
Panel Member
|
Shitanshu Uppal MBA, MBBS, FACOG |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Roberto Vargas MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Vidic |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Andrea Wahner Hendrickson MD |
|
Grant/Research Support
|
| Elucia | Prolynx | Seagen | TORL |
|
Date Completed
|
07/01/2024 |
|
Panel Member
|
Theresa Werner MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Emese Zsiros MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
